Evidence map›Paper›PMID 40778757›Full record

ArticleMicrobiology spectrum2025

Characteristics of four natural poliovirus type 1 variants with six-nucleotide deletion (2,783-2,788 nt) in the VP1 region.

Jie Lin, Lei Zhou, Chenglin Zhu, Jinhang Wei, Bo Lv, Yuan Si, Shuangli Zhu, Tianjiao Ji, Dongyan Wang, Qian Yang and 6 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jie LinNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.ORCID 0009-0007-8054-3775
Lei ZhouNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chenglin ZhuSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Jinhang WeiGuangxi Center for Disease Control and Prevention, Nanning, China.
Bo LvHeilongjiang Center for Disease Control and Prevention, Harbin, China.
Yuan SiShaanxi Center for Disease Control and Prevention, Xian, China.
Shuangli ZhuNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Tianjiao JiNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Dongyan WangNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Qian YangNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jinbo XiaoNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lan YangNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Kaitao XiaoSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Kexin ShaoSchool of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Yong ZhangNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.ORCID 0000-0002-2692-5437
Dongmei YanNational Polio Laboratory, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosecurity, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.ORCID 0000-0002-2817-9431

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the establishment of the Chinese acute flaccid paralysis (AFP) case surveillance system in 1999, around 7,200 strains of poliovirus (PV) type 1 have been identified and isolated. Among these, the VP1 region of 5,649 strains has been sequenced. Based on the existing VP1 region sequence library, four strains of type 1 PV with six-nucleotide deletion in the VP1 region, identified from AFP cases, healthy children, and environmental sewage samples, were identified, and their biological characteristics were investigated. Whole-genome sequence analysis showed that the similarity with the Sabin 1 strain was 99.5-99.8%, and the mutation rate in the VP1 region was only 0.11-0.55%, indicating that these strains are not vaccine-derived PVs. The missing nucleotide is located at positions 2,783-2,788 in the VP1 region, resulting in the deletion of amino acids 102 and 103 at neutralizing antigen site 1 (N-Ag I) in the BC loop. It is worth noting that the neutralization test results showed that the two strains detected from AFP and healthy children evaded immune recognition, whereas the other two from environmental sewage did not. Molecular docking and neutralization antigen site analyzes indicate that the deletion of nucleotides 2,783-2,788 in N-Ag I is not a critical factor leading to the development of neutralization escape variants.IMPORTANCEInterestingly, we observed that the VP3-60 mutation in N-Ag IIIa may be the main reason for the immune evasion of these two viruses. In addition, based on the temperature sensitivity experiments, the four viruses exhibited similar temperature sensitivity to the Sabin 1 strain and their replication ability at 39.5°C was comparable to vaccine-derived polioviruses. Although variants with six-nucleotide deletion (2,783-2,788 nt) in the VP1 region do not cause significant biological changes, they can still spread in the environment and among populations, posing a certain risk of transmission.

Indexed as

Capsid ProteinsPoliovirusSequence DeletionChildChinaGenome, ViralHumansPhylogenyPoliomyelitisSewageWhole Genome SequencingCapsid ProteinsSewageVP1 protein, Poliovirusdeletionpoliovirus type 1VP1

Identifiers

PMID40778757
PMCPMC12403581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.